» Articles » PMID: 33754230

Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function

Overview
Specialty Pharmacology
Date 2021 Mar 23
PMID 33754230
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This chapter provides a general introduction to the dynorphins (DYNs)/kappa opioid receptor (KOR) system, including DYN peptides, neuroanatomy of the DYNs/KOR system, cellular signaling, and in vivo behavioral effects of KOR activation and inhibition. It is intended to serve as a primer for the book and to provide a basic background for the chapters in the book.

Citing Articles

Interaction between corticotropin-releasing factor, orexin, and dynorphin in the infralimbic cortex may mediate exacerbated alcohol-seeking behavior.

Flores-Ramirez F, Illenberger J, Martin-Fardon R Neurobiol Stress. 2024; 33:100695.

PMID: 39640001 PMC: 11617300. DOI: 10.1016/j.ynstr.2024.100695.


Prefrontal cortical dynorphin peptidergic transmission constrains threat-driven behavioral and network states.

Wang H, Flores R, Yarur H, Limoges A, Bravo-Rivera H, Casello S Neuron. 2024; 112(12):2062-2078.e7.

PMID: 38614102 PMC: 11250624. DOI: 10.1016/j.neuron.2024.03.015.


Opioid modulation of prefrontal cortex cells and circuits.

Cole R, Moussawi K, Joffe M Neuropharmacology. 2024; 248:109891.

PMID: 38417545 PMC: 10939756. DOI: 10.1016/j.neuropharm.2024.109891.


NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties.

Huang P, Ho C, Cao D, Inan S, Rawls S, Li M J Pharmacol Exp Ther. 2024; 389(1):106-117.

PMID: 38409113 PMC: 10949162. DOI: 10.1124/jpet.123.001870.


Prefrontal cortical dynorphin peptidergic transmission constrains threat-driven behavioral and network states.

Wang H, Flores R, Yarur H, Limoges A, Bravo-Rivera H, Casello S bioRxiv. 2024; .

PMID: 38283686 PMC: 10822088. DOI: 10.1101/2024.01.08.574700.


References
1.
Chavkin C . Dynorphin--still an extraordinarily potent opioid peptide. Mol Pharmacol. 2012; 83(4):729-36. PMC: 3608442. DOI: 10.1124/mol.112.083337. View

2.
Bilkei-Gorzo A, Erk S, Schurmann B, Mauer D, Michel K, Boecker H . Dynorphins regulate fear memory: from mice to men. J Neurosci. 2012; 32(27):9335-43. PMC: 6622224. DOI: 10.1523/JNEUROSCI.1034-12.2012. View

3.
Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T . Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol. 2002; 435(2-3):259-64. DOI: 10.1016/s0014-2999(01)01588-6. View

4.
Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H . Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology. 2008; 34(3):775-85. PMC: 2873573. DOI: 10.1038/npp.2008.142. View

5.
Mucha R, Herz A . Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl). 1985; 86(3):274-80. DOI: 10.1007/BF00432213. View